Doxycycline hyclate 100 MG tab 400S
Ended Awarded
- Contract number
- SPE2DB25FYP61
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,800
Award facts
- Contract value 100% obligated
- $24,800.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.8K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Doxycycline Hyclate 100 mg tablets (400 count). The delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999B and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facility requirements.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders from the Defense Logistics Agency for diverse medical products ranging from prescription medications to biologics and medical consumables. The company's woman-owned small business status has enabled it to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical distributions to Department of Defense healthcare facilities nationwide. The rapid completion timeline for this doxycycline hyclate order reflects the routine nature of pharmaceutical supply deliveries executed under the existing IDC vehicle.
Quick answers
Who was awarded contract SPE2DB25FYP61?
SPE2DB25FYP61 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FYP61 worth?
The government has obligated $24,800 on SPE2DB25FYP61.
Is contract SPE2DB25FYP61 an order under another contract?
Yes. SPE2DB25FYP61 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP61 competed?
The extent of competition for SPE2DB25FYP61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award